Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00669019
What this trial is testing

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Ended earlyNCT00482911
What this trial is testing

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Who this might be right for
Intraocular MelanomaMalignant Conjunctival Neoplasm
National Institutes of Health Clinical Center (CC) 12
Testing effectiveness (Phase 2)Study completedNCT01196416
What this trial is testing

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT00060125
What this trial is testing

Tipifarnib in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00121225
What this trial is testing

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT00005815
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00680589
What this trial is testing

Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05111574
What this trial is testing

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

Who this might be right for
Anal MelanomaBladder MelanomaCervical Melanoma+14 more
National Cancer Institute (NCI) 101
Testing effectiveness (Phase 2)Active Not RecruitingNCT02858921
What this trial is testing

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 60
Testing effectiveness (Phase 2)Ended earlyNCT04789668
What this trial is testing

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT01693068
What this trial is testing

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Who this might be right for
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
EMD Serono 194
Testing effectiveness (Phase 2)UnknownNCT04749485
What this trial is testing

HX008 for the Treatment of Patients With Malignant Melanoma

Who this might be right for
Melanoma
Taizhou Hanzhong biomedical co. LTD 119
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Not applicableStudy completedNCT01703585
What this trial is testing

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

Who this might be right for
Colorectal CancerBreast CancerGynecological Cancer+3 more
University Health Network, Toronto 45
Testing effectiveness (Phase 2)Study completedNCT00514085
What this trial is testing

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Study completedNCT00866840
What this trial is testing

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Rutgers, The State University of New Jersey 13
Testing effectiveness (Phase 2)Study completedNCT00679289
What this trial is testing

Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaCutaneous Melanoma
Ludwig Institute for Cancer Research 36
Testing effectiveness (Phase 2)UnknownNCT00991250
What this trial is testing

SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
SentoClone AB 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07501104
What this trial is testing

Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma

Who this might be right for
Melanoma (Skin Cancer)
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01551693
What this trial is testing

STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Dana-Farber Cancer Institute 3
Next Page